Results 101 to 110 of about 34,204 (221)

Thoracoscopic Diagnosis of Follicular Lymphoma Relapsing after 13 Years

The Surgery Journal, 2019
Relapse in lymphoproliferative malignancies is not an exceptional entity and generally occurs within the first 2 or 3 years following the primary treatment. Lymph node biopsy is essential for the diagnosis of relapse and treatment.
Serda Kanbur, Onur Derdiyok, Hakan Kiral, Hakan Yilmaz, Mine Demir, Cagatay Tezel, Volkan Baysungur, Serdar Evman   +7 more
doaj   +1 more source

Primary effusion lymphoma in HIV

HIV & AIDS Review, 2011
Abstract Following the widespread use of HAART, malignancy now accounts for nearly 30% of all HIV deaths. Non-AIDS defining malignancies (NADMs) make up a large proportion of this burden, however, AIDS-defining malignancies (ADM) such as non-Hodgkin's Lymphoma (NHL) still makes up nearly 10% of all HIV-deaths. Following recent reclassification by the
Sachil Shah, Larry M. Bush
openaire   +1 more source

Clinical characteristics, treatment response, and survival outcomes in melanoma patients with cavity carcinomatosis: A retrospective analysis

International Journal of Cancer, Volume 158, Issue 9, Page 2418-2428, 1 May 2026.
What's new? Cavity carcinomatosis, a late manifestation of cancer, fuels tumor formation throughout a large area, most commonly the peritoneal and pleural cavities. The condition also can lead to resistance to otherwise effective treatment strategies.
Zhongqiao Lin, Li Zhu, Yuyang Huang, Lizhu Chen, Yuping Lu, Yu Chen, Jing Lin   +6 more
wiley   +1 more source

Repurposing Cytarabine for Treating Primary Effusion Lymphoma by Targeting Kaposi’s Sarcoma-Associated Herpesvirus Latent and Lytic Replications

mBio, 2018
Oncogenic Kaposi’s sarcoma-associated herpesvirus (KSHV) is etiologically linked to primary effusion lymphoma (PEL), an aggressive and nontreatable malignancy commonly found in AIDS patients.
Marion Gruffaz, Shenghua Zhou, Karthik Vasan, Teresa Rushing, Qing Liu Michael, Chu Lu, Jae U. Jung, Shou-Jiang Gao   +7 more
doaj   +1 more source

Prophylactic use of carvedilol to prevent ventricular dysfunction in patients with cancer treated with doxorubicin [PDF]

, 2018
Objective: Deterioration in ventricular function is often observed in patients treated with anthracyclines for cancer. There is a paucity of evidence on interventions that might provide cardio-protection.
Abrar, Mohammed Burhan, Abuosa, Ahmed Mohamed, Ahmed, Adel H., Andejani, Abdulwahab, Cleland, John G.F., Elshiekh, Ayman Hassan, Kholeif, Mona A., Kinsara, Abdulhalim Jamal, Qureshi, Kahekashan   +8 more
core   +1 more source

Treatment Outcomes With Novel Targeted and Immunotherapeutic Regimens in CAYA Hodgkin Lymphoma: A Retrospective Study

Cancer Innovation, Volume 5, Issue 2, April 2026.
Compared to conventional chemotherapy, treatment with BV‐AVD ± R in CAYA Hodgkin lymphoma patients resulted in comparable response rates (ORR: 96.4% vs. 95.4%) but with a marked reduction in Grade 4 hematologic toxicity (25.6% vs. 61.2%). BV‐AVD monotherapy yielded a higher ORR than BV‐AVD + R (100% vs. 93.9%).
Mengqing Xie, Meng Yuan, Mengwei Ren, Jing Tian, Shengyu Zhou, Xiaohui He, Yan Qin, Peng Liu, Jianliang Yang, Mengyuan Han, Fei Ma, Sheng Yang, Sidan Li   +12 more
wiley   +1 more source

Dendritic cells: Key players in human herpesvirus 8 infection and pathogenesis [PDF]

, 2014
Human herpesvirus 8 (HHV-8; Kaposi's sarcoma-associated herpesvirus) is an oncogenic gammaherpesvirus that primarily infects cells of the immune and vascular systems.
Akula, Akula, Akula, Ambroziak, Armenian, Banchereau, Beltman, Birkmann, Blasig, Boshoff, Brayfield, Cai, Campadelli-Fiume, Carbone, Carbone, Castleman, Cesarman, Cesarman, Cesarman, Chan, Chang, Chehimi, Cheong, Cirone, Cirone, Clark, Coscoy, Cull, Cutler, de Witte, Della Bella, Dupin, Duus, Edelman, El-Daly, Enk, Farah, Frisch, Furio, Geissmann, Gessain, Gill, Granelli-Piperno, Gregory, Hahn, Hassman, Hensler, Hensler, Hislop, Hogg, Holmgren, Huang, Ishido, Iwasaki, Jacobson, Jenner, Jotwani, Kerur, King, Klechevsky, Knowlton, Knowlton, Koelle, Kwun, Lang, Li, Liao, Lin, Lisco, Liu, Mesri, Mesri, Mitterer, Montgomery, Moore, Munthe, Munz, Myoung, Nador, Nador, Neipel, Nickoloff, Oksenhendler, Orsini, Osman, Otsuki, Park, Pica, Qu, Rappocciolo, Rappocciolo, Rappocciolo, Ratzinger, Reed, Relloso, Rettig, Rezaee, Robey, Said, Sallusto, Samols, Santarelli, Sharma-Walia, Simonelli, Soilleux, Soilleux, Soulier, Stebbing, Ueno, Valladeau, Vieira, Walling, Wang, Wang, Wang, Wang, West, Wilkinson, Yan, Yi   +119 more
core   +1 more source

Sustained Belinostat‐Induced Metabolic Response and Tolerability in Heavily Pretreated Relapsed/Refractory Angioimmunoblastic T‐Cell Lymphoma: A Case Report

Clinical Case Reports, Volume 14, Issue 4, April 2026.
ABSTRACT Angioimmunoblastic T‐cell lymphoma (AITL), a rare and aggressive subtype of peripheral T‐cell lymphoma (PTCL), often demonstrates resistance to standard therapies. The optimal therapeutic approach for relapsed/refractory (R/R) AITL remains therefore uncertain and challenging, with an unmet need for effective treatment options.
Vassiliki Labropoulou, Evgenia Verigou, Eleni P. Kourea, Maria Liga, Dimitrios Tsokanas, Krisela‐Christina Valera, Alexandros Spyridonidis   +6 more
wiley   +1 more source

Primary intestinal lymphangiectasia (Waldmann's disease) [PDF]

, 2008
Primary intestinal lymphangiectasia (PIL) is a rare disorder characterized by dilated intestinal lacteals resulting in lymph leakage into the small bowel lumen and responsible for protein-losing enteropathy leading to lymphopenia, hypoalbuminemia and ...
Stéphane Vignes, Jérôme Bellanger, TA Waldmann, V Boursier, WL Tift, P Le Bougeant, PA Vardy, A Schmider, L Misery, A Munck, C Goktan, WS Lee, R Rao, B Lobo, R Lenzhofer, JB O'Driscoll, E Karg, VN Perisic, F Iida, S Baricault, S Kalman, H Sahli, H Herfarth, P Samman, RC Hennekam, R Hokari, P Chamouard, S Vignes, YH Fang, C Rivet, NT Chiu, HL Dorne, G Maconi, A Fakhri, RL Stevens, JP Mazzie, DM Yang, KG Burnand, Y So, W Strober, PL Weiden, D Heresbach, IJ Fuss, JD Davidson, VP Petersen, P Wilkinson, PT Sum, AP Douglas, SP Mistilis, L Laster, JL Steinfeld, OS Popovic, A Ploddi, AJ van Tilburg, SS Rao, M Stockmann, L Mertens, MM Weiser, K Kobayashi, SM Edworthy, M Gattorno, TA Waldmann, Y Bouhnik, S Broder, O Shpilberg, D Laharie, M Ward, J Guma, C Hallevy, SL Cole, I Marie, GH Jeffries, V Alfano, K Aoyagi, K Mine, JE MacLean, AB Ballinger, G Kuroiwa, RD Klingenberg, S Reichlin, H Nakabayashi, AL Warshaw, CP Chen, TA Fleisher   +83 more
core   +2 more sources

Analysis of SWI Complex Subunits in 69 Cases of TTF‐1 Negative Non‐Small Cell Lung Carcinoma

Diagnostic Cytopathology, Volume 54, Issue 4, Page 278-284, April 2026.
ABSTRACT Non‐small cell lung carcinomas, not otherwise specified (NSCLC‐NOS) with a specific signature including high‐grade hepatoid/clear cell morphology, negative lung panel mutational analysis, negative TTF‐1/Napsin A staining can be reported as a morphologic variant of an aggressive carcinoma with loss of one of the subunits of the SWI/SNF ...
Ramin Zargham, Feng (Selina) Ji, Tarek Bismar   +2 more
wiley   +1 more source